BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24608429)

  • 21. Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.
    Hsu A; Zhang W; Lee JF; An J; Ekambaram P; Liu J; Honn KV; Klinge CM; Lee MJ
    Int J Oncol; 2012 May; 40(5):1619-26. PubMed ID: 22344462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological Significance and Prognostic Value of Surfactant Protein D in Cancer.
    Mangogna A; Belmonte B; Agostinis C; Ricci G; Gulino A; Ferrara I; Zanconati F; Tripodo C; Romano F; Kishore U; Bulla R
    Front Immunol; 2018; 9():1748. PubMed ID: 30127783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.
    Fujioka N; Nguyen J; Chen C; Li Y; Pasrija T; Niehans G; Johnson KN; Gupta V; Kratzke RA; Gupta K
    Anesth Analg; 2011 Dec; 113(6):1353-64. PubMed ID: 22003224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor.
    Domagala T; Konstantopoulos N; Smyth F; Jorissen RN; Fabri L; Geleick D; Lax I; Schlessinger J; Sawyer W; Howlett GJ; Burgess AW; Nice EC
    Growth Factors; 2000; 18(1):11-29. PubMed ID: 10831070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope.
    Makabe K; Yokoyama T; Uehara S; Uchikubo-Kamo T; Shirouzu M; Kimura K; Tsumoto K; Asano R; Tanaka Y; Kumagai I
    Sci Rep; 2021 Mar; 11(1):5790. PubMed ID: 33707468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF.
    Chen R; Jin G; McIntyre TM
    J Biol Chem; 2017 Jun; 292(24):10112-10122. PubMed ID: 28455445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin α5 Suppresses the Phosphorylation of Epidermal Growth Factor Receptor and Its Cellular Signaling of Cell Proliferation via N-Glycosylation.
    Hang Q; Isaji T; Hou S; Im S; Fukuda T; Gu J
    J Biol Chem; 2015 Dec; 290(49):29345-60. PubMed ID: 26483551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways.
    Tito C; Genovese I; Giamogante F; Benedetti A; Miglietta S; Barazzuol L; Cristiano L; Iaiza A; Carolini S; De Angelis L; Masciarelli S; Nottola SA; Familiari G; Petrozza V; Lauriola M; Tamagnone L; Ilari A; Calì T; Valdivia HH; Valdivia CR; Colotti G; Fazi F
    Cell Mol Life Sci; 2023 Jul; 80(8):202. PubMed ID: 37442828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
    Moriai T; Kobrin MS; Hope C; Speck L; Korc M
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-133 inhibits the growth and metastasis of the human lung cancer cells by targeting epidermal growth factor receptor.
    Liu S; Chen J; Zhang T; Chen H
    J BUON; 2019; 24(3):929-935. PubMed ID: 31424644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.
    Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L
    J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two EGF molecules contribute additively to stabilization of the EGFR dimer.
    Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J
    EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis.
    Breindel JL; Haskins JW; Cowell EP; Zhao M; Nguyen DX; Stern DF
    Cancer Res; 2013 Aug; 73(16):5053-65. PubMed ID: 23794705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
    Sah JF; Eckert RL; Chandraratna RA; Rorke EA
    J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling.
    Maemoto T; Kitai Y; Takahashi R; Shoji H; Yamada S; Takei S; Ito D; Muromoto R; Kashiwakura JI; Handa H; Hashimoto A; Hashimoto S; Ose T; Oritani K; Matsuda T
    J Biol Chem; 2023 Jan; 299(1):102724. PubMed ID: 36410436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 38. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.
    Hong SY; Shih YP; Li T; Carraway KL; Lo SH
    Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kindlin-2 interacts with and stabilizes EGFR and is required for EGF-induced breast cancer cell migration.
    Guo B; Gao J; Zhan J; Zhang H
    Cancer Lett; 2015 Jun; 361(2):271-81. PubMed ID: 25790908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DMP-1 promoter-associated antisense strand non-coding RNA, panRNA-DMP-1, physically associates with EGFR to repress EGF-induced squamous cell carcinoma migration.
    Suzuki S; Yuan H; Hirata-Tsuchiya S; Yoshida K; Sato A; Nemoto E; Shiba H; Yamada S
    Mol Cell Biochem; 2021 Apr; 476(4):1673-1690. PubMed ID: 33420898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.